Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Picroliv now reported to possess promising antiallergic activity

Feb. 9, 1999

Byk Gulden's roflumilast in clinical trials; spotlight on PDE4 inhibitors for asthma

Feb. 9, 1999

Antiallergic/antiasthmatic agents from Kaken acting specifically on eosinophils

Feb. 9, 1999

Discovery's Surfaxin shows positive phase II results in MAS

Feb. 9, 1999

Purinoceptor P2 receptor antagonists in early development at Astra

Feb. 8, 1999

Successful phase II trial of chronic bronchitis treatment reported by Milkhaus

Feb. 5, 1999

Novel mast cell inhibitor tested preclinically for allergy prevention

Feb. 5, 1999

Schering-Plough seeks approval for pediatric use of Nasonex nasal spray

Feb. 4, 1999

Grant to be used to study effect of P-113 in chronic lung infections

Feb. 4, 1999

Rigel and Pfizer to collaborate in identifying drug targets in allergy and asthma

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.